Treating obesity with behavior change, generic anti-obesity medications, and GLP-1 seems to reduce the risk profile associated with all of these [cardiometabolic] diseases, Frank added
This story was produced by LMNT and reviewed and distributed by Stacker .
Glucagon-like peptide-1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP) are the two main incretins and are secreted by enteroendocrine L- and K-cells, respectively
GLP-1 medications work by: Slowing stomach emptying, so you feel full longer Suppressing hunger signals in the brain Increasing insulin release and reducing blood sugar spikes Reducing glucagon, a hormone that raises blood sugar This helps patients lose weight naturally while maintaining balanced blood sugar levels
Tirzepatide helped me lose weight and control my appetite
Gradual dose escalation protocol for improved tolerability